Abstract
This study explored the potential molecular associations of gut microbiota-derived metabolites with oligozoospermia and asthenozoospermia and identified key candidate targets, pathways, and microbiota–substrate–metabolite–target relationships. Human gut microbiota, substrates, metabolites, and host genes were obtained from gutMGene. Metabolite targets were predicted using SwissTargetPrediction and SEA, while disease-related targets were collected from GeneCards, OMIM, and CTD. Candidate targets were identified by intersection analysis. Protein–protein interaction networks were constructed to prioritize highly connected candidate targets, followed by GO and KEGG enrichment analyses. SwissADME and ADMETlab were used to characterize physicochemical properties and predict toxicity, respectively. An M-S-M-T network was constructed, and molecular docking was performed to assess potential metabolite–target interactions. In total, 1518 gut microbiota metabolite-related targets were obtained, yielding 22 candidate targets for oligozoospermia and 17 for asthenozoospermia. CXCL8, IL6, TNF, and TP53 were identified as shared highly connected candidate targets. GO analysis indicated enrichment in responses to bacterial-origin molecules, lipopolysaccharide response, inflammation, cytokine activity, and redox homeostasis. KEGG analysis highlighted MAPK, PI3K-Akt, TNF, HIF-1, and cytokine–cytokine receptor interaction pathways. The M-S-M-T network suggested a potential association involving Clostridium sporogenes, tyrosine/phenylalanine-derived aromatic metabolites, and CXCL8, based on the integration of reported microbial metabolic relationships and predicted metabolite–target interactions. Molecular docking yielded predicted binding scores for 3-phenylpropionic acid and 4-hydroxyphenylacetic acid with CXCL8. This network pharmacology study identified CXCL8, IL6, TNF, and TP53 as candidate targets potentially linking gut microbiota-derived metabolites with oligozoospermia and asthenozoospermia. The predicted associations involving aromatic metabolites and CXCL8 provide hypotheses for further investigation. Experimental and clinical validation is required to determine whether these associations have biological relevance in male reproductive dysfunction.